RELX had a 2% increase in underlying revenue at its scientific, technical and medical unit for the first nine months, and said it expects the unit to post modest full-year growth. "RELX Says Nine-Month Underlying Revenue Grew on Year," at 0608 GMT, incorrectly stated that the revenue rise and the guidance were both for RELX as a whole in the first and last paragraphs. The revenue rise and the guidance both refer to the scientific, technical and medical unit alone. The error was also present in "*RELX Underlying Rev. +2% in the First Nine Months" at 0600 GMT.

(END) Dow Jones Newswires

October 26, 2017 04:41 ET (08:41 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.
Grafico Azioni RELX (EU:REN)
Storico
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di RELX
Grafico Azioni RELX (EU:REN)
Storico
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di RELX